Sarah Houben-Wilke
Overview
Explore the profile of Sarah Houben-Wilke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
1070
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Waeijen-Smit K, Houben-Wilke S, Posthuma R, de Jong F, Janssen D, van Loon N, et al.
Chronic Obstr Pulm Dis
. 2023 Jan;
10(2):127-138.
PMID: 36599097
Rationale: A significant reduction in hospitalizations for acute exacerbations of COPD (AECOPDs) has been reported during the coronavirus disease 2019 (COVID-19) pandemic. It remains unclear whether this reduction is the...
12.
Muijsenberg A, Houben-Wilke S, Zeng Y, Spruit M, Janssen D
Patient Educ Couns
. 2022 Dec;
107:107588.
PMID: 36502561
Objectives: To develop learner-centered education, knowledge about learning styles and factors that affect the ability to learn in patients and their significant others are essential. The present scoping review aims...
13.
Houben-Wilke S, Goertz Y, Delbressine J, Vaes A, Meys R, Machado F, et al.
JMIR Ment Health
. 2022 Feb;
9(2):e33704.
PMID: 35200155
Background: The psychological impact of COVID-19 can be substantial. However, knowledge about long-term psychological outcomes in patients with COVID-19 is scarce. Objective: In this longitudinal, observational study, we aimed to...
14.
Augustin I, Franssen F, Houben-Wilke S, Janssen D, Gaffron S, Pennings H, et al.
PLoS One
. 2022 Feb;
17(2):e0263657.
PMID: 35176055
Background: Clusters of COPD patients have been reported in order to individualize the treatment program. Neither co-morbidity clusters, nor integrated respiratory physiomics clusters contributed to a better prediction of outcomes....
15.
Vaes A, Spruit M, Franssen F, van t Hul A, Burtin C, Gloeckl R, et al.
Eur Respir J
. 2021 Dec;
59(6).
PMID: 34949697
No abstract available.
16.
Van Herck M, Goertz Y, Houben-Wilke S, Machado F, Meys R, Delbressine J, et al.
J Med Internet Res
. 2021 Sep;
23(9):e30274.
PMID: 34494964
Background: Fatigue is the most commonly reported symptom in patients with persistent complaints following COVID-19 (ie, long COVID). Longitudinal studies examining the intensity of fatigue and differentiating between physical and...
17.
Waeijen-Smit K, Reynaert N, Beijers R, Houben-Wilke S, Simons S, Spruit M, et al.
Sci Rep
. 2021 Aug;
11(1):15883.
PMID: 34354097
Hyaluronic acid (HA) is a key component of the extracellular matrix. HA and its metabolism are suggested to be altered in the lungs of patients with chronic obstructive pulmonary disease...
18.
Delbressine J, Machado F, Goertz Y, Van Herck M, Meys R, Houben-Wilke S, et al.
Int J Environ Res Public Health
. 2021 Jul;
18(11).
PMID: 34205086
A subgroup of patients recovering from COVID-19 experience persistent symptoms, decreased quality of life, increased dependency on others for personal care and impaired performance of activities of daily living. However,...
19.
Houben-Wilke S, Delbressine J, Vaes A, Goertz Y, Meys R, Machado F, et al.
J Patient Exp
. 2021 Jun;
8:2374373521997222.
PMID: 34179387
To become a proactive and informed partner in postacute coronavirus disease 2019 (COVID-19) management, patients need to have the knowledge, skills, and confidence to self-manage COVID-19-related health challenges. Due to...
20.
Vaes A, Goertz Y, Van Herck M, Machado F, Meys R, Delbressine J, et al.
ERJ Open Res
. 2021 May;
7(2).
PMID: 34041295
Background: It remains unknown whether and to what extent members of online "long COVID" peer support groups remain symptomatic and limited over time. Therefore, we aimed to evaluate symptoms in...